Bank of Montreal
SIOX

Bank of Montreal’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bank of Montreal’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-50
Closed -$1K – 4917
2018
Q3 		$1K Hold
50
– – ﹤0.01% 4636
2018
Q2 		$1K Buy
+50
New +$737 ﹤0.01% 4627

Other funds holding SIOX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $227M AUM 41.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of Montreal's SIOX Position: Q2 2022 in Review

Bank of Montreal sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2022, closing a stake of 10,000 shares — an estimated $7K sold.

Bank of Montreal first reported a position in SIOX in Q1 2016 and held it in 15 quarters. The position peaked at $935K in Q3 2021. 41 funds tracked by Wall St. Rank hold SIOX as of Q2 2022.

  • Bank of Montreal reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Bank of Montreal sold 10,000 Sio Gene Therapies Inc. Common Stock shares in Q2 2022, an estimated $7K.
  • Bank of Montreal first reported a position in Sio Gene Therapies Inc. Common Stock in Q1 2016 and held it in 15 quarters.
  • Bank of Montreal's Sio Gene Therapies Inc. Common Stock position peaked at $935K in Q3 2021.
  • 41 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.